Clinical trial
A Phase III Trial to Promote Recovery From Covid 19 With Combined Doxycycline and Ivermectin Along Standard Care
NCT04523831 is registered in ClinicalTrials.gov with Dhaka Medical College as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase III Trial to Promote Recovery From Covid 19 With Combined Doxycycline and Ivermectin Along Standard Care
- Lead sponsor
- Dhaka Medical College
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- June 1, 2020
- Completion date
- September 10, 2020
- Enrollment
- 400 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
covid19